4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Glial Cell Tumors in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu-Chen, LY; Traynor, JR; Wang, Q | 1 |
1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Glial Cell Tumors
Article | Year |
---|---|
Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
Topics: Analgesics, Opioid; Animals; Benzamides; Cell Line, Tumor; Colforsin; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Glioma; Glycosylation; Humans; Kidney; Mice; Mitogen-Activated Protein Kinases; Morphine; Neuroblastoma; Piperazines; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Recombinant Fusion Proteins; RGS Proteins; RNA Interference; Signal Transduction; Transfection | 2009 |